About Pharmacology 2019

3rd World Congress on Pharmacology and Clinical Research

This 3rd Pharma Series by Cenetri Publishing Group is an exclusive event consisting of renowned keynote addresses, Plenary presentations and Panel discussions & Networking designed specifically for attendees from academic and government institutions along with highly esteemed members of leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. World Congress on Pharmacology and Clinical Research was designed with 40 presentations, case studies and panel discussions focused on the theme: Encompass Key Issues In Research/Clinical Studies Related To The Field Of Pharmacology And Pharmacotherapeutics.

This conference will provide the finest platform where you can deliberate the prominence of pharmacology & regulatory affairs that covers research on the toxicological an pharmacological effects of environmental contaminants, pharmacologic concerns on both experimental and clinical levels, clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Clinopharma 2019 welcomes you to attend World Congress on Pharmacology and Clinical Research which will be held during July 15-17, 2019 at Kula Lumpur, Malaysia.

Scope and Importance

Clinical pharmacology encompasses all aspects of the relationship between drugs and humans. It is the only medical specialty in the NHS focusing on the safe, effective and economic use of medicines. It is a diverse discipline that both sustains and advances best healthcare.

Opportunities & challenges for pharmaceutical industry:

  • Slowed market growth
  • Policy reform
  • The future of biosimilars
  • Drug approval stagnation
  • Venture Capital Flow
  • Patient-centric healthcare

Scientific Sessions

  • Clinical Pharmacology
  • Pharmacogenomics
  • Pharmaceutics and Pharmacokinetics
  • Medicinal Chemistry & Pharmacy Practice
  • Pharmacoepidemiology
  • Pharmacotherapy and Posology
  • Neuropharmacology
  • Psychopharmacology
  • Pediatrics Pharmacology
  • Pharmacovigilance & Clinical Pharmacy
  • Toxicology
  • Theoretical & Behavioral Pharmacology
  • Drug Design and Discovery
  • Drug Delivery and Formulation
  • Drug safety
  • Bioequivalence and Bioavailability
  • Adverse Drug Reaction and Treatment
  • Clinical research and Drug Legislation
  • Clinical and Medical Case Reports
  • Pharmaceuticals and Personal Care Products

Societies and associations of Pharmacology & Regulatory Affairs

  • Safety Pharmacology Society
  • American Society for Pharmacology
  • Royal Pharmaceutical Society
  • Canadian Society of Pharmacology and Therapeutics
  • Association for Ocular Pharmacology
  • Regulatory Affairs Professionals Society
  • Canadian Association of Professionals in Regulatory Affairs
  • The European Association for Clinical Pharmacology and Therapeutics (EACPT)
  • Rocky Mountain Regulatory Affairs Society
  • Belgian Regulatory Affairs Society
  • Korean Society of Pharmacology
  • Malaysian Society of Pharmacology and Physiology (MSPP)
  • Pharmacological Society of Taiwan
  • Japanese Pharmacological Society
  • Pharmacy and Drug Control
  • The Federation of European Pharmacological Societies

Reasons to Attend ?

  • This conference provides the chance to Meet and network 100+ industry leaders and peers, with co-located events under Pharmacology and gain critical advises from industrial experts on the related regulation matters.
  • To grasp and gain the quality information in terms of breadth and depth of key topics on production registration, submission, pharmacovigilance, clinical regulatory requirements and other topics with respect to the scientific sessions.
  • To take the opportunity of exchanging, circulation and gaining the knowledge and ideas for the future prospects.

Target Audience

  • Faculty of Pharmaceutical Universities, Students, Scientists and Researchers
  • Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
  • Business Entrepreneurs, Training Institutes, Software developing companies
  • Manufacturing Medical Devices Companies, CRO and Data Management Companies

Market report

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.


  • Reason 1: Drug Companies Can Charge Whatever Price They Want.
  • Reason 2: Insurance Companies Are Also Charging You More.
  • Reason 3: Old Drugs Are Reformulated as Costly 'New' Drugs.
  • Reason 4: Generic Drug Shortages Can Trigger Massive Price Increases.
  • Reason 5: Specialty Drugs Are Costing All of Us.